BASF Redefines the Future of Personal Care at In-Cosmetics Asia 2025 with “Beyond Beauty – Where Innovation Meets Tomorrow” At In-Cosmetics Asia 2025, taking place from November 4 to 6 in Bangkok, BASF, a global leader in sustainable chemistry, invites…
Merck and Boltz Redefine AI Innovation in Protein Structure Prediction Through Global Hackathon In a landmark collaboration blending open science, artificial intelligence, and molecular biology, Merck, a leading science and technology company, joined forces with the Boltz team to host…
IMCD Showcases Greener, Smarter, and Patient-Centric Pharmaceutical Innovations at CPHI Frankfurt 2025 a global leader in the distribution and formulation of specialty chemicals and ingredients, has announced its participation at CPHI Frankfurt 2025, taking place from 28–30 October. At this…
Evonik Expands Its Asian Footprint with the Launch of “Alu5” — a New State-of-the-Art Fumed Alumina Plant in Japan Evonik, one of the world’s leading specialty chemicals companies, has officially inaugurated its first state-of-the-art fumed alumina production facility, named “Alu5”,…
Arrowhead Pharmaceuticals Announces Completion of Global Licensing and Collaboration Agreement with Novartis Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a leading biopharmaceutical company focused on developing innovative RNA interference (RNAi) therapeutics, announced today that its previously disclosed global licensing and collaboration agreement…
Exploring Hydrogen Water in Psychological Treatment Echo is shining a spotlight on peer-reviewed research that suggests hydrogen-rich water may have a supportive role in psychological care. The study, recently published in Health Psychology Research, examined how hydrogen water could enhance…
Marginum, a Finnish medical technology company, has reached a major milestone with the announcement that its flagship device, HIVEN®, has been cleared for the CE mark under the European Union’s Medical Device Regulation (MDR). This certification, achieved in just over…
Aptar Pharma, a global leader in drug delivery and active material science solutions, announced that its Unidose Liquid System (UDS) has been selected as the delivery technology for Enbumyst™ (Bumetanide Nasal Spray) 0.5 mg, recently approved by the U.S. Food…
C-Further today announced that Great Ormond Street Hospital Charity (GOSH Charity), the UK’s largest dedicated charitable funder of child health research, has joined Cancer Research Horizons and LifeArc as a core partner in the international consortium. Together, the organizations will…
Ollin Biosciences Launches with $100 Million Financing to Advance Next-Generation Ophthalmology Therapies Ollin Biosciences, Inc., a newly established clinical-stage biopharmaceutical company, announced its launch with an initial $100 million financing round led by ARCH Venture Partners, Mubadala Capital, and Monograph…
Tasca Therapeutics Doses First Patient in Phase 1/2 Clinical Trial of CP-383 for Advanced Solid Tumors Tasca Therapeutics, a clinical-stage biotechnology company dedicated to developing targeted therapies for genetically defined cancers, announced today that the first patient has been dosed…
Ionis Pharmaceuticals, Inc. marked a major milestone today, celebrating the 10th anniversary of Surf Away+, its signature adaptive community event. What began as an initiative to provide people with spinal muscular atrophy (SMA) access to adaptive surfing has evolved into…